Aggregate report
Last reviewedAn aggregate report is a periodic safety document that evaluates the cumulative safety data for a medicine over a defined interval, rather than describing a single case. The main types are the DSUR during clinical development and the PBRER, PSUR and PADER after approval.
Key facts
| Purpose | Give regulators a periodic, overall evaluation of a product's safety and benefit-risk profile |
|---|---|
| Before approval | DSUR (ICH E2F) |
| After approval | PBRER or PSUR (ICH E2C(R2)), PADER (21 CFR 314.80) |
| Contrast | An ICSR reports one case; an aggregate report evaluates all cases together |
How it differs from case reporting
Individual case safety reports are submitted as events occur. An aggregate report looks across all of those cases, together with clinical trial, literature and exposure data, to assess whether the product's safety profile or benefit-risk balance has changed during the reporting interval.
Sources
Read more
Part of our guide to Pharmacovigilance Aggregate Reports: DSUR, PBRER, PSUR and PADER

